Ignite Creation Date:
2024-05-06 @ 3:53 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04798339
Status:
RECRUITING
Last Update Posted:
2024-04-08
First Post:
2021-03-11
Brief Title:
Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESA
Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Organization:
H Lee Moffitt Cancer Center and Research Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-30
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-06-28
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-11
First Submit QC Date:
March 11 2021
Study First Post Date:
2021-03-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-23
Last Update Post Date:
2024-04-08
Last Update Post Date Type:
ACTUAL